MicroRNAs and Aneurysm Formation

Trends in Cardiovascular Medicine

Volumn 21, Issue 6, 2011, Pages 172-177

  Boon, Reinier A ^a   Dimmeler, Stefanie ^a  

^a GOETHE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; GELATINASE A; GELATINASE B; LOCKED NUCLEIC ACID; MICRORNA; MICRORNA 143; MICRORNA 145; MICRORNA 21; MICRORNA 26A; MICRORNA 29; MICRORNA 29A; MICRORNA 29B; PROTEIN P53; SCLEROPROTEIN; SMAD1 PROTEIN; SMAD4 PROTEIN; TRANSFORMING GROWTH FACTOR BETA;

ABDOMINAL AORTA ANEURYSM; ATHEROSCLEROSIS; BLOOD VESSEL WALL; DOWN REGULATION; ENDOTHELIUM CELL; EXTRACELLULAR MATRIX; GENE EXPRESSION REGULATION; HUMAN; INFLAMMATORY CELL; MARFAN SYNDROME; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RNA PROCESSING; THORACIC AORTA ANEURYSM; TRANSCRIPTION REGULATION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

ANEURYSM; ANIMALS; DOWN-REGULATION; GENE EXPRESSION REGULATION; HUMANS; MICE; MICRORNAS; UP-REGULATION;

EID: 84863864175     PISSN: 10501738     EISSN: 18732615     Source Type: Journal    
DOI: 10.1016/j.tcm.2012.05.005     Document Type: Review

References (42)

1. Albinsson S., Suarez Y., Skoura A., et al. MicroRNAs are necessary for vascular smooth muscle growth, differentiation, and function. Arterioscler Thromb Vasc Biol 2010, 30:1118-1126.
2. Bartel D.P. MicroRNAs: Target recognition and regulatory functions. Cell 2009, 136:215-233.
3. Baxter B.T., Terrin M.C., Dalman R.L. Medical management of small abdominal aortic aneurysms. Circulation 2008, 117:1883-1889.
4. Boettger T., Beetz N., Kostin S., et al. Acquisition of the contractile phenotype by murine arterial smooth muscle cells depends on the Mir143/145 gene cluster. J Clin Invest 2009, 119:2634-2647.
5. Bonauer A., Boon R.A., Dimmeler S. Vascular microRNAs. Curr Drug Targets 2010, 11:943-949.
6. Bonauer A., Carmona G., Iwasaki M., et al. MicroRNA-92a controls angiogenesis and functional recovery of ischemic tissues in mice. Science 2009, 324:1710-1713.
7. Boon R.A., Seeger T., Heydt S., et al. MicroRNA-29 in aortic dilation: Implications for aneurysm formation. Circ Res 2011, 109:1115-1119.
8. Chase A.J., Newby A.C. Regulation of matrix metalloproteinase (matrixin) genes in blood vessels: A multi-step recruitment model for pathological remodelling. J Vasc Res 2003, 40:329-343.
9. Chen K.C., Wang Y.S., Hu C.Y., et al. OxLDL up-regulates microRNA-29b, leading to epigenetic modifications of MMP-2/MMP-9 genes: A novel mechanism for cardiovascular diseases. FASEB J 2011, 25:1718-1728.
10. Cordes K.R., Sheehy N.T., White M.P., et al. miR-145 and miR-143 regulate smooth muscle cell fate and plasticity. Nature 2009, 460:705-710.
11. Cushing L., Kuang P.P., Qian J., et al. miR-29 is a major regulator of genes associated with pulmonary fibrosis. Am J Respir Cell Mol Biol 2011, 45:287-294.
12. Davis B.N., Hilyard A.C., Lagna G., Hata A. SMAD proteins control DROSHA-mediated microRNA maturation. Nature 2008, 454:56-61.
13. Elia L., Quintavalle M., Zhang J., et al. The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: Correlates with human disease. Cell Death Differ 2009, 16:1590-1598.
14. Fish J.E., Santoro M.M., Morton S.U., et al. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008, 15:272-284.
15. Hergenreider E., Heydt S., Tréguer K., et al. Atheroprotective communication between endothelial cells and smooth muscle cells through miRNAs. Nat Cell Biol 2012, 14:249-256.
16. Hwang H.W., Wentzel E.A., Mendell J.T. A hexanucleotide element directs microRNA nuclear import. Science 2007, 315:97-100.
17. Iorio M.V., Croce C.M. MicroRNA dysregulation in cancer: Diagnostics, monitoring and therapeutics. A comprehensive review. EMBO Mol Med 2012, 4:143-159.
18. Jones J.A., Stroud R.E., O'Quinn E.C., et al. Selective microRNA suppression in human thoracic aneurysms: Relationship of miR-29a to aortic size and proteolytic induction. Circ Cardiovasc Genet 2011, 4:605-613.
19. Krützfeldt J., Rajewsky N., Braich R., et al. Silencing of microRNAs in vivo with "antagomirs". Nature 2005, 438:685-689.
20. Leeper N.J., Raiesdana A., Kojima Y., et al. MicroRNA-26a is a novel regulator of vascular smooth muscle cell function. J Cell Physiol 2011, 226:1035-1043.
21. Liao M., Zou S., Weng J., et al. A microRNA profile comparison between thoracic aortic dissection and normal thoracic aorta indicates the potential role of microRNAs in contributing to thoracic aortic dissection pathogenesis. J Vasc Surg 2011, 53:1341-1349.
22. Lindsay M.E., Dietz H.C. Lessons on the pathogenesis of aneurysm from heritable conditions. Nature 2011, 473:308-316.
23. Maegdefessel L., Azuma J., Toh R., et al. MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion. Sci Transl Med 2012, 4. 122ra122.
24. Maegdefessel L., Azuma J., Toh R., et al. Inhibition of microRNA-29b reduces murine abdominal aortic aneurysm development. J Clin Invest 2012, 122:497-506.
25. Merk D.R., Chin J.T., Dake B.A., et al. miR-29b participates in early aneurysm development in Marfan syndrome. Circ Res 2012, 110:312-324.
26. Mott J.L., Kobayashi S., Bronk S.F., Gores G.J. miR-29 regulates Mcl-1 protein expression and apoptosis. Oncogene 2007, 26:6133-6140.
27. Oviedo-Orta E., Bermudez-Fajardo A., Karanam S., et al. Comparison of MMP-2 and MMP-9 secretion from T helper 0, 1 and 2 lymphocytes alone and in coculture with macrophages. Immunology 2008, 124:42-50.
28. Qin W., Chung A.C.K., Huang X.R., et al. TGF-β/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 2011, 22:1462-1474.
29. Roderburg C., Urban G.W., Bettermann K., et al. Micro-RNA profiling reveals a role for miR-29 in human and murine liver fibrosis. Hepatology 2011, 53:209-218.
30. Singh K., Bønaa K.H., Jacobsen B.K., et al. Prevalence of and risk factors for abdominal aortic aneurysms in a population-based study: The Tromsø study. Am J Epidemiol 2001, 154:236-244.
31. Steele R., Mott J.L., Ray R.B. MBP-1 upregulates miR-29b, which represses Mcl-1, collagens, and matrix-metalloproteinase-2 in prostate cancer cells. Genes Cancer 2010, 1:381-387.
32. Suárez Y., Fernández-Hernando C., Yu J., et al. Dicer-dependent endothelial microRNAs are necessary for postnatal angiogenesis. Proc Natl Acad Sci U S A 2008, 105:14082-14087.
33. Ugalde A.P., Ramsay A.J., de la Rosa J., et al. Aging and chronic DNA damage response activate a regulatory pathway involving miR-29 and p53. EMBO J 2011, 30:2219-2232.
34. van Rooij E. The art of microRNA research. Circ Res 2011, 108:219-234.
35. van Rooij E., Sutherland L.B., Liu N., et al. A signature pattern of stress-responsive microRNAs that can evoke cardiac hypertrophy and heart failure. Proc Natl Acad Sci U S A 2006, 103:18255-18260.
36. van Rooij E., Sutherland L.B., Thatcher J.E., et al. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci U S A 2008, 105:13027-13032.
37. Van Solingen C., Seghers L., Bijkerk R., et al. Antagomir-mediated silencing of endothelial cell specific microRNA-126 impairs ischemia-induced angiogenesis. J Cell Mol Med 2009, 13:1577-1585.
38. Wang H., Garzon R., Sun H., et al. NF-κB-YY1-miR-29 regulatory circuitry in skeletal myogenesis and rhabdomyosarcoma. Cancer Cell 2008, 14:369-381.
39. Wang S., Aurora A.B., Johnson B.A., et al. The endothelial-specific microRNA miR-126 governs vascular integrity and angiogenesis. Dev Cell 2008, 15:261-271.
40. Zernecke A., Bidzhekov K., Noels H., et al. Delivery of MicroRNA-126 by apoptotic bodies induces CXCL12-dependent vascular protection. Sci Signal 2009, 2:ra81.
41. Zhang P., Huang A., Ferruzzi J., et al. Inhibition of microRNA-29 enhances elastin levels in cells haploinsufficient for elastin and in bioengineered vessels: Brief report. Arterioscler Thromb Vasc Biol 2012, 32:756-759.
42. Zhang Z., Zou J., Wang G.K., et al. Uracils at nucleotide position 9-11 are required for the rapid turnover of miR-29 family. Nucleic Acids Res 2011, 39:4387-4395.